Report Feature
The future of the hydroxychloroquine market looks promising with opportunities in hospitals and clinics. The global hydroxychloroquine market is expected to grow with a CAGR of 33%-35% from 2020 to 2025. The major growth drivers for this market are the recent outbreak of viruses, such as coronavirus disease (COVID-19); increasing incidence of malaria in developing countries; and rising autoimmune diseases, such as rheumatoid arthritis and lupus erythematosus.
A total of XX figures / charts and XX tables are provided in this more than 150-page report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global hydroxychloroquine market report, please download the report brochure.
In this market, 400 mg is the largest dosage type segment of hydroxychloroquine, whereas development of COVID-19 is the largest application. Growth in various segments of the hydroxychloroquine market are given below:
The study includes trends and forecast for the global hydroxychloroquine market by dosage type, sales channel, application, and region as follows:
By Dosage Type [Value ($ Million) shipment analysis for 2014 – 2025]:
200 mg
400 mg
800 mg
By Sales Channel [Value ($ Million) shipment analysis for 2014 – 2025]:
Online
Offline
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
Coronavirus Disease (COVID-19)
Malaria
Rheumatoid Arthritis
Lupus Erythematosus
Others
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
North America
United States
Canada
Mexico
Europe
United Kingdom
Germany
France
Asia Pacific
China
India
Japan
The Rest of the World
Brazil
Some of the hydroxychloroquine companies profiled in this report include Novartis, Amneal Pharmaceuticals, Laurus Labs, Prasco Laboratories, Cardinal Health, Advanz Pharma, Dr. Reddy's Laboratories, Covis Pharmaceuticals, Mylan, and McKesson.
Lucintel forecasts that 400 mg will remain the largest dosage type segment over the forecast period due to increasing prevalence of autoimmune diseases and malaria.
Within this market, COVID-19 will remain the highest growing application segment over the forecast period due to rapidly increasing cases of COVID-19 all over the world.
Asia Pacific will remain the largest region over the forecast period due to rising cases of maleria, rapidly increasing cases of COVID-19, and presence of major pharmaceutical manufacturing units in the region.
|
Features of the Global Hydroxychloroquine Market |
|
|
This report answers following key questions |
|
Q.1 What are some of the most promising potential, high-growth opportunities for the global hydroxychloroquine market by dosage type (200 mg, 400 mg, and 800 mg), sales channel (online and offline), application (COVID-19, malaria, rheumatoid arthritis, lupus erythematosus, and others), and region (North America, Europe, Asia Pacific, and Rest of the World)? Q.2 Which segments will grow at a faster pace and why? Q.3 Which region will grow at a faster pace and why? Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global hydroxychloroquine market? Q.5 What are the business risks and threats to the global hydroxychloroquine market? Q.6 What are the emerging trends in this hydroxychloroquine market and the reasons behind them? Q.7 What are some changing demands of customers in this hydroxychloroquine market? Q.8 What are the new developments in this hydroxychloroquine market? Which companies are leading these developments? Q.9 Who are the major players in this hydroxychloroquine market? What strategic initiatives are being implemented by key players for business growth? Q.10 What are some of the competitive products and processes in this hydroxychloroquine market, and how big of a threat do they pose for loss of market share via material or product substitution? Q.11 What M&A activities did take place in the last five years in the global hydroxychloroquine market? |
Report Scope
| Key Features | Description |
| Base Year for Estimation | 2019 |
|
Trend Period (Actual Estimates) |
2014-2019 |
| Forecast Period | 2020-2025 |
| Pages | More than 150 |
| Market Representation / Units | Revenue in US $ Million |
| Report Coverage | Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling |
| Market Segments | Dosage Type (200 Mg, 400 Mg, and 800 Mg), Sales Channel (Online and Offline), and Application (COVID-19, Malaria, Rheumatoid Arthritis, Lupus Erythematosus, and Others) |
Regional Scope |
North America (USA, Mexico, and Canada), Europe (United Kingdom, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil) |
| Customization | 10% Customization without Any Additional Cost |
Table of Contents
1. Executive Summary
7.2 Emerging Trends in the Global Hydroxychloroquine Market
4.1 Global Hydroxychloroquine Market by Region
4.2.1 Market by Dosage Type: 200mg, 400mg, and 800mg
4.2.2 Market by Sales Channel: Online and Offline
4.2.3 Market by Application: Coronavirus Disease (COVID 19), Malaria, Rheumatoid Arthritis, Lupus Erythematosus, and Others
4.2.4 The United States Hydroxychloroquine Market
4.2.5 The Canadian Hydroxychloroquine Market
4.2.6 The Mexican Hydroxychloroquine Market
4.3.1 Market by Dosage Type: 200mg, 400mg, and 800mg
4.3.2 Market by Sales Channel: Online and Offline
4.3.3 Market by Application: Coronavirus Disease (COVID 19), Malaria, Rheumatoid Arthritis, Lupus Erythematosus, and Others
4.3.4 The Hydroxychloroquine Market of United Kingdom
4.3.5 The German Hydroxychloroquine Market
4.3.6 The French Hydroxychloroquine Market
4.4.1 Market by Dosage Type: 200mg, 400mg, and 800mg
4.4.2 Market by Sales Channel: Online and Offline
4.4.3 Market by Application: Coronavirus Disease (COVID 19), Malaria, Rheumatoid Arthritis, Lupus Erythematosus, and Others
4.4.4 The Chinese Hydroxychloroquine Market
4.4.5 The Indian Hydroxychloroquine Market
4.4.6 The Japanese Hydroxychloroquine Market
7.1.1 Growth Opportunities for the Global Hydroxychloroquine Market by Dosage Type
7.1.2 Growth Opportunities for the Global Hydroxychloroquine Market by Sales Channel
7.1.3 Growth Opportunities for the Global Hydroxychloroquine Market by Application
7.1.4 Growth Opportunities for the Global Hydroxychloroquine Market by Region
Methodology
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
- In-depth interviews of the major players in this market
- Detailed secondary research from competitors’ financial statements and published data
- Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
- A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
Buy Now
Choose a license that fits your team. Instant PDF delivery.
Prices exclude taxes. Instant delivery. Custom licensing available on request.
